Creating the "new normal" post-Coronavirus world-web-communication replacing face-to-face interaction [0.03%]
后冠状病毒时代，创造“新常态”-网络沟通代替面对面交流
Wolfgang Hilbe,Andreas Pircher,Thorsten Füreder et al.
Wolfgang Hilbe et al.
Editorial
Memo. 2020;13(3):245-246. DOI:10.1007/s12254-020-00636-7 2020
Thorsten Fuereder,Eberhard Gunsilius,Rupert Bartsch et al.
Thorsten Fuereder et al.
Editorial
Memo. 2020;13(2):135-138. DOI:10.1007/s12254-020-00611-2 2020
Development of treatment and clinical results in childhood AML in Austria (1993-2013) [0.03%]
奥地利（1993-2013年）儿童急性髓系白血病的治疗进展及临床疗效
Heidrun Boztug,Nora Mühlegger,Evgenia Glogova et al.
Heidrun Boztug et al.
Background: Since the early 1990s, three consecutive pediatric acute myeloid leukemia (AML) trials have been performed in Austria (AML-Berlin-Frankfurt-Münster (BFM) 93, AML-BFM 98, and AML-BFM 2004) in close cooperation...
Investigation of seasonal frequency and pathogens in febrile neutropenia [0.03%]
发热性中性粒细胞减少症的季节性频率及病原研究
Seray Karagöz Özdemir,Utku Iltar,Ozan Salim et al.
Seray Karagöz Özdemir et al.
Background: In patients with hematological malignancies, febrile neutropenia (FEN) is the most frequent complication and the most important cause of mortality. Various risk factors have been identified for severe infectio...
Barbara Kiesewetter,Markus Raderer
Barbara Kiesewetter
Several compounds have recently been approved for the systemic treatment of advanced well-differentiated neuroendocrine tumours (NET) of gastroenteropancreatic (GEP) or lung origin. Based on the PROMID and CLARINET trials, somatostatin anal...
Fabian Steinkohl,Renate Pichler,Daniel Junker
Fabian Steinkohl
Magnetic resonance imaging (MRI) of the prostate has become the gold standard for visualization of prostate cancer. Prostate MRI is usually performed as multiparametric MRI (mpMRI). Since mpMRI has several drawbacks, a biparametric MRI (bpM...
ASCO 2018: highlights of urothelial cancer and prostate cancer [0.03%]
2018年美国临床肿瘤学会（ASCO）会议亮点：尿路上皮癌和前列腺癌治疗新进展
Renate Pichler,Wolfgang Horninger,Isabel Heidegger
Renate Pichler
Prostate cancer and urothelial carcinoma are the two most common urological cancers. The aim of this short review is to highlight abstracts from this year's ASCO Annual Meeting. The phase III SPCG-13 trial showed no difference in biochemica...
Rupert Bartsch,Elisabeth Bergen
Rupert Bartsch
At the 2018 ASCO Annual Meeting, data from several interesting studies in HER2-positive metastatic breast cancer were presented. While not immediately practice changing, these trials indicate the future directions of drug development in thi...
Gabriel Rinnerthaler,Simon Peter Gampenrieder,Richard Greil
Gabriel Rinnerthaler
This article reviews the clinically most relevant presentations at the American Society of Clinical Oncology (ASCO) annual meeting 2018 on the topic of metastatic breast cancer. In the randomized placebo-controlled phase 3 trial MONALEESA-3...
Gabriele Gamerith,Florian Kocher,Jakob Rudzki et al.
Gabriele Gamerith et al.
Non-small cell lung cancer (NSCLC) treatment was booming at this year's ASCO 2018 meeting as several well-performed phase III trials with practice-changing potential were presented. Thereby immune checkpoint blockade (ICB) consolidated its ...